An anti-coronavirus drug developed by Defence Research and Development Organisation (DRDO) will be launched today, with Union Defence Minister Rajnath Singh distributing around 10,000 doses to some hospitals in the national capital.
The drug, called 2-deoxy-D-glucose or 2-DG, was developed by a DRDO lab in collaboration with the Hyderabad-based pharma giant, Dr Reddy’s Laboratories. Drugs Controller General of India (DCGI), the country’s top drug regulator, has approved the medicine for emergency use.
The medicine was found to be safe for COVID-19 patients in phase 2 trials, conducted between May and October last year. It was found to be effective in cutting short the hospital stays of Covid patients and reducing their supplemental oxygen dependence.
A kind of pseudo glucose molecule in the drug stops the virus in its tracks, the defence body says.
The medicine comes in powder form and can be taken with water.
2-DG is one of the few medicines across the world that have been designed specifically to treat COVID-19, which, as of now, has no cure. Doctors use several experimental drugs and procedures, including Remdevisir, Ivermectin, plasma therapy and some steroids, to treat the deadly infection.
Curtesy : NDTV NEWS